Oura Inc. (Ticker: OURA US) is a Finnish-founded health technology company operating a health intelligence platform centered on Oura Ring, a smart ring that tracks more than 50 health metrics, including sleep, activity, stress, readiness, women’s health, metabolic health and heart health. The company serves millions of members globally and also works with research teams, healthcare providers, sports organizations and other partners.

Oura plans to list on Nasdaq on September 30, 2026, following expected pricing on September 29. The company has filed to offer 50 million shares at a price range of $40-$44 per share, representing an offer size of approximately $2.1 billion at the midpoint. Approximately 27% of the shares are primary and 73% are secondary, meaning most of the IPO proceeds are expected to go to selling shareholders rather than the company. J.P. Morgan, Goldman Sachs, Morgan Stanley, Allen & Co. and Jefferies are acting as bookrunners.